NCT07781800 Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health
| NCT ID | NCT07781800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2026-10-14 |
| Primary Completion | 2028-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2026-10-14 with a primary completion date of 2028-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess how individual patient social stressors are associated with barriers to care by analyzing a patient navigator system. Patient navigators will connect patients with unmet social needs with community resources.
Eligibility Criteria
Eligibility Criteria: * Diagnosed with breast cancer (any stage). * Currently being treated for breast cancer by a breast medical oncologist at Siteman Cancer Center North County. This includes any treatment, PO or IV, including hormonal therapy. It does not include patients enrolled in clinical trials. * At least 18 years of age. * English-speaker. * Verbally consented to navigation services.
Contact & Investigator
Emily L Podany, MD, MPHS
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT07781800 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07781800 currently recruiting?
Yes, NCT07781800 is actively recruiting participants. Contact the research team at elpodany@wustl.edu for enrollment information.
Where is the NCT07781800 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07781800 clinical trial?
NCT07781800 is sponsored by Washington University School of Medicine. The principal investigator is Emily L Podany, MD, MPHS at Washington University School of Medicine. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.